Cargando…

Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case–Control and Mendelian Randomization Study

BACKGROUND: Coronary artery disease (CAD) ranks the leading cause of death worldwide, and inflammation has been implicated in all stages of CAD and is considered to contribute to the pathophysiological basis of atherogenesis. METHODS: Here, we implemented a case–control study and a two-sample Mendel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Zhang, Yanqun, Guo, Xue, Wu, Yuanyuan, Huang, Ruo, Han, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124014/ https://www.ncbi.nlm.nih.gov/pubmed/34007203 http://dx.doi.org/10.2147/PGPM.S303362

Ejemplares similares

Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease
por: Ding, Ding, et al.
Publicado: (2015)

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2020)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
por: Lee, Seong-Kyu
Publicado: (2017)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans
por: Yousefzadeh, Matthew J., et al.
Publicado: (2017)

High-fat diet increases the level of circulating Monocyte Chemoattractant Protein-1 in Wistar rats, independent of obesity
por: Syarif, et al.
Publicado: (2021)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Circulating levels of monocyte chemoattractant protein-1 and interleukin-7 in women who have undergone bilateral salpingo-oophorectomy
por: Tani, Anna, et al.
Publicado: (2013)

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013)

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
por: Martín-Reyes, Roberto, et al.
Publicado: (2016)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Circulating Vitamin E Levels and Risk of Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study
por: Wang, Tao, et al.
Publicado: (2019)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients
por: Talbert, Erin E., et al.
Publicado: (2018)

Circulating proteins and peripheral artery disease risk: observational and Mendelian randomization analyses
por: Yuan, Shuai, et al.
Publicado: (2023)

Protective Effects of Circulating TIMP3 on Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study
por: Chen, Heng, et al.
Publicado: (2022)

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Yong, Kok-Khun, et al.
Publicado: (2016)

Data on early postoperative changes in aqueous monocyte chemoattractant protein-1 levels after phacoemulsification
por: Kawai, Motofumi, et al.
Publicado: (2016)

Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy
por: Zungsontiporn, Nath, et al.
Publicado: (2016)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes via Epigenetic Mechanisms in Coronary Heart Disease
por: Jia, Sujie, et al.
Publicado: (2019)

Analytical performance of a canine ELISA monocyte chemoattractant protein-1 assay for use in cats and evaluation of circulating levels in normal weight and obese cats
por: Stenberg, Kathrine, et al.
Publicado: (2022)

Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population
por: He, Dan, et al.
Publicado: (2015)

Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial
por: Waiyaput, Wanwisa, et al.
Publicado: (2017)

Circulating adipokine levels and preeclampsia: A bidirectional Mendelian randomization study
por: Chen, Xiaoyan, et al.
Publicado: (2022)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Does Monocyte Chemoattractant Protein-1 Levels Determine the Prognosis of Covid-19 Disease in Kidney Transplant Recipients?
por: Akin, Emrah, et al.
Publicado: (2023)

Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes
por: Zineh, Issam, et al.
Publicado: (2009)

Chemoattractant-induced activation of c-fos gene expression in human monocytes
Publicado: (1987)

Decreased Serum Monocyte Chemoattractant Protein-1 (MCP-1) Expression in Patients with Upper Gastrointestinal Bleeding
por: Xing, Guohui, et al.
Publicado: (2019)

Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r9neids96209g2v818hjlokmtg